400-859-2883
Your location:Home >News center >Industry News

Industry News

08-192022

Trodelvy: Any Chance Against Dato-DXd and…

Here, we will discuss what are the advantages of Trodelvy, and which is superior in the field of breast cancer treatment, Trodelvy vs. Dato-DXd, Enhertu?

Trodelvy: Any Chance Against Dato-DXd and Enhertu?
08-162022

"Click Chemistry" Holds Promise…

"Click Chemistry" is a class of reactions involving the formation of carbon-heteroatom bonds, which are characterized by high yield and selectivity.

08-062022

SGLT2 Inhibitors in Diabetes and Heart Fa…

Sodium-glucose cotransporter-2 (SGLT2) inhibitors have been shown effeciency in diabetes and heart failure.

SGLT2 Inhibitors in Diabetes and Heart Failure
07-252022

Antibody + PROTAC: The Emergence of Degra…

Proteolysis targeting chimera, or PROTACs, are heterobifunctional molecules that are rapidly revolutionizing the market landscape in the biomedical field. These heterobifunctional molecules a…

Antibody + PROTAC: The Emergence of Degrader-Antibody Conjugates
07-212022

A Look into Antibody–drug conjugates (AD…

Approved ADC drugs list and the ongoing trails with hot ADC targets such as HER2, EGFR, TROP2, FRα, CLDN18.2,, c-Met, Nectin-4.

A Look into Antibody–drug conjugates (ADCs) Targets
07-182022

Overview of Triple Negative Breast Cancer…

This article provides an overview of triple negative breast cancer and a summary of FDA-approved therapies.

Overview of Triple Negative Breast Cancer And FDA Approved Therapies